Compounds > l 368899
Page last updated: 2024-09-03

l 368899 and naloxone

l 368899 has been researched along with naloxone in 1 studies

Compound Research Comparison

Studies
(l 368899)		Trials
(l 368899)		Recent Studies (post-2010)
(l 368899)		Studies
(naloxone)		Trials
(naloxone)		Recent Studies (post-2010) (naloxone)
4603020,1341,2573,321

Protein Interaction Comparison

ProteinTaxonomyl 368899 (IC50)naloxone (IC50)
Cytochrome P450 2D6Homo sapiens (human)2
Delta-type opioid receptorMus musculus (house mouse)0.043
Delta-type opioid receptorRattus norvegicus (Norway rat)0.0219
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0019
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0019
Mu-type opioid receptorHomo sapiens (human)0.0397
Delta-type opioid receptorHomo sapiens (human)0.1896
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.05
Kappa-type opioid receptorHomo sapiens (human)0.0795
Mu-type opioid receptorMus musculus (house mouse)0.0154
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0089
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.0055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumei, S; Nozu, T; Ohhira, M; Okumura, T1

Other Studies

1 other study(ies) available for l 368899 and naloxone

ArticleYear
Central oxytocin signaling mediates the central orexin-induced visceral antinociception through the opioid system in conscious rats.
    Physiology & behavior, 2019, 01-01, Volume: 198

    Topics: Adenosine A1 Receptor Antagonists; Analgesics; Animals; Camphanes; Cannabinoid Receptor Agonists; Dopamine D2 Receptor Antagonists; Hormone Antagonists; Indoles; Male; Naloxone; Narcotic Antagonists; Nociception; Oxytocin; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Reflex; Sulpiride; Xanthines

2019